BASSI, ROSARIA
BASSI, ROSARIA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Hyaluronic acid-based nanoparticles for pulmonary delivery of poorly soluble drugs
2026 C.I. Camara, C. Ricci, L. Bertocchi, R. Bassi, A. Bianchera, R. Bettini, E. Del Favero
Effect of CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor on lipid metabolism in human bronchial epithelial cells
2025 D. Dobi, N. Loberto, L. Mauri, R. Bassi, E. Chiricozzi, G. Lunghi, M. Aureli
Anti-inflammatory activity of Pseudomonas aeruginosa DEV phage in cystic fibrosis models
2025 M. Cafora, D. Dobi, J.N.G. William, F. Forti, L. Belleri, N. Loberto, R. Bassi, S. Carbone, M. Locati, M. Aureli, F. Briani, A. Pistocchi
Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets
2025 M. Rufail, R. Bassi, P. Giussani
Metabolic and Structural Consequences of GM3 Synthase Deficiency: Insights from an HEK293-T Knockout Model
2025 E. Chiricozzi, G. Lunghi, M. Valsecchi, E.V. Carsana, R. Bassi, E. Di Biase, D. Dobi, M.G. Ciampa, L. Mauri, M. Aureli, K. Inamori, J. Inokuchi, S. Sonnino, M. Fazzari
Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells
2025 D. Dobi, A. Rimessi, N. Loberto, L. Mauri, R. Bassi, E. Chiricozzi, D. Olioso, G. Pellielo, P. Pinton, V. Bezzerri, G. Cabrini, G. Lippi, A. Tamanini, G. Lunghi, M. Aureli
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)
2024 D.Z. Ciobanu, N. Liessi, V. Tomati, V. Capurro, S.M. Bertozzi, M. Summa, R. Bertorelli, N. Loberto, D. Dobi, M. Aureli, L. Nobbio, T. Bandiera, N. Pedemonte, R. Bassi, A. Armirotti
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
2023 R. Bassi, M. Dei Cas, C. Tringali, F. Compostella, R. Paroni, P. Giussani
Cross‐talk between CFTR and sphingolipids in cystic fibrosis
2023 D. Dobi, N. Loberto, R. Bassi, A.S. Pistocchi, G. Lunghi, A. Tamanini, M. Aureli
β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of Neurodegeneration
2022 G. Lunghi, E.V. Carsana, N. Loberto, L. Cioccarelli, S. Prioni, L. Mauri, R. Bassi, S. Duga, L. Straniero, R. Asselta, G. Soldà, A. Di Fonzo, E. Frattini, M. Magni, N. Liessi, A. Armirotti, E. Ferrari, M. Samarani, M. Aureli
Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models
2022 M. Cafora, N. Poerio, F. Forti, N. Loberto, D. Pin, R. Bassi, M. Aureli, F. Briani, A. Pistocchi, M. Fraziano
Hybrid lipid/polymer nanoparticles to tackle the cystic fibrosis mucus barrier in siRNA delivery to the lungs : does PEGylation make the difference?
2022 G. Conte, G. Costabile, D. Baldassi, V. Rondelli, R. Bassi, D. Colombo, G. Linardos, E.V. Fiscarelli, R. Sorrentino, A. Miro, F. Quaglia, P. Brocca, I. D'Angelo, O.M. Merkel, F. Ungaro
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A
2022 E.V. Carsana, G. Lunghi, S. Prioni, L. Mauri, N. Loberto, A. Prinetti, F.A. Zucca, R. Bassi, S. Sonnino, E. Chiricozzi, S. Duga, L. Straniero, R. Asselta, G. Soldà, M. Samarani, M. Aureli
Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival
2021 R. Bassi, S. Brambilla, C. Tringali, P. Giussani
Hyaluronic acid-dexamethasone nanoparticles for local adjunct therapy of lung inflammation
2021 C.I. Camara, L. Bertocchi, C. Ricci, R. Bassi, A. Bianchera, L. Cantu', R. Bettini, E. Del Favero
GM1 as adjuvant of innovative therapies for cystic fibrosis disease
2020 G. Mancini, N. Loberto, D. Olioso, M.C. Dechecchi, G. Cabrini, L. Mauri, R. Bassi, D. Schiumarini, E. Chiricozzi, G. Lippi, E. Pesce, S. Sonnino, N. Pedemonte, A. Tamanini, M. Aureli
Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis
2020 N. Loberto, G. Mancini, R. Bassi, E.V. Carsana, A. Tamanini, N. Pedemonte, M. Cristina Dechecchi, S. Sonnino, M. Aureli
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease
2019 M. De Fenza, D. D'Alonzo, A. Esposito, S. Munari, N. Loberto, A. Santangelo, I. Lampronti, A. Tamanini, A. Rossi, S. Ranucci, I. De Fino, A. Bragonzi, M. Aureli, R. Bassi, M. Tironi, G. Lippi, R. Gambari, G. Cabrini, G. Palumbo, M.C. Dechecchi, A. Guaragna
Crosstalk between sphingosine-1-phosphate and EGFR signalling pathways enhances human glioblastoma cell invasiveness
2018 M.G. Cattaneo, C. Vanetti, M. Samarani, M. Aureli, R. Bassi, S. Sonnino, P. Giussani
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells
2018 V. Murdica, G. Mancini, N. Loberto, R. Bassi, P. Giussani, N. Di Muzio, C. Deantoni, A. Prinetti, M. Aureli, S. Sonnino